Key points are not available for this paper at this time.
Acapatamab-induced PSA response in patients who received prior lutetium-PSMA therapy
Dorff et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: